Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans

Journal of Clinical Immunology

Volumn 17, Issue 6, 1997, Pages 448-454

  Aggarwal, Sudeepta ^a   Tsuruo, Takashi ^b   Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aging; P Glycoprotein; T cell subsets

Indexed keywords

ADENOSINE TRIPHOSPHATE; AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GLYCOPROTEIN P; MONOCLONAL ANTIBODY;

AGING; ARTICLE; AUTOIMMUNITY; CELL SUBPOPULATION; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MEMORY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGING; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; GENE EXPRESSION; GENES, MDR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; P-GLYCOPROTEIN; T-LYMPHOCYTE SUBSETS;

EID: 0031442280     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027363525408     Document Type: Article

References (44)

1. Miller RA: Aging: Primer and prospectus. Science 273:70-76, 1997
2. Weksler ME: Immunology and the elderly: An historical perspective for future international action. Mech Age Dev 93:1-6, 1997
3. Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL, Holbrook NJ, Adler WH: Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J Clin Invest 81:96-109, 1988
4. Fernandes G, Gupta S: Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J Clin Immunol 1:141-148, 1981
5. Gupta S: Autologous mixed lymphocyte reaction in man. IX. Autologous mixed lymphocyte reaction and lymphocyte subsets in aging humans. Scand J Immunol 19:187-191, 1984
6. Gupta S: Membrane signal transduction in T cells in aging humans. Ann NY Acad Sci 568:277-282, 1989
7. Philosophe B, Miller RA: Diminished calcium signal generation in subsets of T lymphocytes that predominate old mice. J Gerontology 45:B87-B93, 1990
8. Saini A, Sai T: Age related impairment of early and late events of signal transduction in mouse immune cells. Life Sci 52:1759-1765, 1993
9. + T cells from young and aged mice. J Immunol 145:1295-1302, 1990
10. + T cell subsets from aging humans. J Immunol 150:33A, 1993
11. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993
12. Juranka PF, Zastawny RL, Ling V: P-glycoprotein: Multidrug resistance and a superfamily of membrane associated transport protein. FASEB J 3:2583-2592, 1989
13. Roninson IB: The role of MDR1 gene (P-glycoprotein) in multiple drug resistance in vitro and in vivo. Biochem Pharmacol 43:95-102, 1992
14. Wilson CM, Serrano AE, Wasely A, Bogneschutz MP, Shankar AH, Wirth DF: Amplification of a gene related to mammalian mdr genes in drug resistant Plasmodium falciparum. Science 244: 1184-1186, 1989
15. Gollapudi S, Gupta S: Human immunodeficiency virus 1 (HIV-1)-induced P-glycoprotein expression. Biochem Biophys Res Commun 171:1002-1007, 1990
16. Gupta S: P-glycoprotein expression and regulation. Age-related changes and potential effects of drug therapy. Drugs Aging 7:19-29, 1995
17. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoitic stem cells. Cell 66:85-94, 1991
18. Gupta S, Aggarwal S: P-glycoprotein in cells of the human immune system, Immunulogist 4:86-90, 1996
19. Higgins CF: ABC transporters: From microorganisms to man. Annu Rev Cell Biol 8:67-113, 1992
20. + T cells: A role in cytotoxic effector function. J Clin Immunol 12:451-458, 1992
21. Young PR, Krasney PA: Stimulation of interleukin 1b secretion in monkey kidney cells by coexpression of the mammalian P-glycoprotein MDR1. In Pathophysiology and Pharmacology of Cytokines, P Ghezzi, A Mantovani (eds). Augusta, GA, Biomedical Press, 1992, pp 21-27
22. Raghu G, Park SW, Roninson IB, Mechetner EB: Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol 24:1258-1264, 1996
23. Drach J, Gsur A, Hamilton G, Zhao S, Angericr J, Fiegl M, Zojer N, Raderer M, Haberi I, Andreeff M, Huber H: Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes. Blood 88:1747-1754, 1996
24. Wilisch A, Noller A, Handgretinger R, Weger S, Nussler V, Niethammer D, Probst H, Gekeler V: Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood. Cancer Lett 69:139-148, 1993
25. Hamada H, Tsuruo T: Functional role of the 170-180 kda glycoprotein specific to drug resistant tumor cells as treated by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785-7789, 1986
26. Chomczynski P, Sacchi N: Single step method for RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
27. Aggarwal S, Gupta A, Tsuruo T, Gupta S: Differential expression of P-glycoprotein in cord blood and peripheral blood lymphocyte subpopulations. Int J Oncol 8:1063-1068, 1996
28. Kessel D, Beck WT, Kukuraga D, Schultz V: Characterization of multidrug resistance by fluorescent dyes. Cancer Res 51:4665-4670, 1991
29. Foxwell BMJ, Mackie A, Ling V, Ryffel B: Identification of multidrug resistance related P-gP as a cyclosporin binding protein. Mol Pharmacol 36:543-546, 1989
30. Saeki T, Ueda K, Tanigawara T, Hori R, Komano T: Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268:6077-6080, 1993
31. Gupta S, Gollapudi S: P-glycoprotein (MDR 1 gene product) in cells of the immune system: Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J Clin Immunol 13:289-301, 1993
32. Gupta S, Aggarwal S: Role of P-glycoprotein in the secretion of basic fibroblast growth factor. J Allergy Clin Immunol 95:345, 1995
33. Klimecki WT, Futscher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451-2458, 1994
34. Hegewisch-Becker S, Fliegner M, Tsuruo T, Zander A, Zeller W, Hossfield DK: P-glycoprotein expression in normal and reactive bone marrows. Br J Cancer 67:430-435, 1993
35. Witkowski JM, Miller RA: Increased function of P-glycoprotein in T lymphocytes subsets of aging mice. J Immunol 150:1296-1306, 1993
36. Pilarski LM, Paine D, McElhaney JK, Cass CE, Belch AR: Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes. Am J Hematol 49:328-335, 1995
37. Lee WY, Yin X-M, Vitteta HS: Functional and ontogentic analysis of murine CD45RB and CD45RB on CD4+ T cells. J Immunol 144:3288-3295, 1990
38. Bottomly K, Luqman M, Greenbaum L, Carding S, West J, Pasqualini T, Murphy DB: A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 19:617-623, 1989
39. Gabriel H, Schmitt B, Kindermann W: Age-related increase of CD45RO+ lymphocytes in physically active adults. Eur J Immunol 23:2704-2706, 1995
40. De Paoli P, Battinstin S, Santini GF: Age-related changes in human lymphocyte subsets: Progressive reduction of the CD4 CD45RA (suppressor inducer) population. Clin Immunol Immunopathol 48:290-296, 1988
41. Gupta S, Tsuruo T, Gollapudi S: Multidrug resistance gene 1 product in human T cell subsets: Role of protein kinase C isoforms and regulation by cyclosporin A. Adv Exp Med Biol 323:39-47, 1992
42. Chambers TC, McAvoy KM, Jacobs JW, Eilon G: Protein kinase C phosphorylates P-glycoprotein in multidrug resistant KB carcinoma cells. J Biol Chem 265:7679-7686, 1990
43. Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS: Analysis of multidrug resistance-associated protein (MRP) in normal and malignant hematopoitic cells. Cancer Res 54:4676-4679, 1994
44. Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC, Scheper RJ: The drug resistance-related protein LRP is the human major vault protein. Nature Med 1:578-582, 1995